You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 醫脈通漲超7% 高盛料純利年均複合快速增長可期
格隆匯 09-21 10:50
格隆匯9月21日丨醫脈通(2192.HK)今早低開高走,現報36港元,漲7.62%,總市值256億港元。高盛發研報稱,相信公司作為內地最大線上專業醫師平台,在短期細化市場解決方案需求增加及長遠智能病人管理業務增長支持下,料收入及純利年均複合快速增長可期。公司專屬科技、內部生成能力,以及策劃社羣,料受惠於內地數碼護理市場推廣開支增加。該行料醫脈通2021至2023年各年收入分別3.6億、6.42億及11.11億元人民幣(下同),每股純利料分別27分、32分及47分,首予醫脈通“中性”評級,目標價35港元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account